Propanc Biopharma Inc (PPCB)

[Diggnun21]

Honest Company: I find it very forthcoming that Propanc offered a "no guarantee" of funding in their 10K/10Q. These guys are true professionals and have integrity. I do not see them performing a RS given their dedication to their shareholders. My DD tells me the scientific board and board of advisors are very resourceful. They will be able to procure the funding they need to bring the Propanc drug line to human trials, and eventually the marketplace--they have the connections. For example, take Professor John Smyth:

**Emeritus Professor of Medical Oncology in the University of Edinburgh, where his major research interest has been the development and evaluation of new anti-cancer drugs.

**He has published over 300 papers and is past Editor-in-Chief of the European Journal of Cancer.

**He served for several years on the UK Committee on Safety of Medicines; currently Chair's the Expert Advisory Group for Oncology & Haematology for the Commission on Human Medicines and has served on the Scientific Advisory Group for Oncology to the EMEA.

**He is a fellow of the Royal College of Physicians of Edinburgh and London, and fellow of the Royal Society of Edinburgh.

**He is a past-president of the European Society of Medical Oncology and was from 2005 - 2007 President of the Federation of European Cancer Societies.